| Entry |
|
|---|
| Name |
Talipexole (INN) |
|---|
| Formula |
C10H15N3S
|
|---|
| Exact mass |
209.0987
|
|---|
| Mol weight |
209.31
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01472 Dopamine agonist
DG01468 Dopamine D2-receptor agonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiparkinsonian, Dopamine D2 receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07213 | Dopamine receptor agonists/antagonists |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01472 Dopamine agonist
DG01468 Dopamine D2-receptor agonist
DG01326 Talipexole
D08558 Talipexole
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD2
D08558 Talipexole (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01472 Dopamine agonist
DG01468 Dopamine D2-receptor agonist
DG01326 Talipexole
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 14
1 C8y C 22.5400 -16.1000
2 C8y C 22.5400 -17.5000
3 N5x N 23.8700 -17.9200
4 C8y C 24.7100 -16.8000
5 S2x S 23.8700 -15.6800
6 C1x C 21.4200 -15.1900
7 C1x C 20.0900 -15.5400
8 N1y N 19.4600 -16.8000
9 C1x C 20.0900 -18.0600
10 C1x C 21.4200 -18.3400
11 C1b C 18.0600 -16.8000
12 N1a N 26.1100 -16.8000
13 C2b C 17.3600 -15.6100
14 C2a C 15.9600 -15.6100
BOND 15
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 1 5 1
6 7 8 1
7 8 9 1
8 6 7 1
9 2 10 1
10 1 6 1
11 9 10 1
12 8 11 1
13 4 12 1
14 11 13 1
15 13 14 2
|
|---|
